Christchurch Medicines Information Service

  • Home
  • Enquiries
  • News
  • Bulletins
  • Medicines in patient groups
    • Medicines and liver impairment
    • Medicines and renal impairment
    • Medicines and elderly
    • Medicines and breastfeeding
    • Medicines and pregnancy
  • Resources
    • Complementary & Alternative Medicines
    • Therapeutic Drug Monitoring
    • Useful links
  • About us
  • Medicines and COVID-19
Filter results:

Bulletins - Administration

Filter by category:
AdministrationAdverse drug reactionsCannabis-based productsComplementary and Alternative Medicines (CAMs)COVID-19Drug comparisonsInteractionsNew medicineOtherPharmacokineticPregnancy/Breastfeeding

World Antimicrobial Awareness Week – Penicillin Allergy - November 17, 2021

World Antimicrobial Awareness Week – Penicillin Allergy - November 17, 2021

Empagliflozin and dulaglutide in type 2 diabetes - April 6, 2021

NZ is funding two medicines in new classes for the treatment of type 2 diabetes.1 These will be second line options after metformin, and favoured for patients at high risk of cardiovascular or renal complications. They are subject to special authority criteria.1-3 Empagliflozin, a sodium-glucose ...

Oral Anticoagulants – Rivaroxaban and Dabigatran - October 1, 2019

Rivaroxaban (Factor Xa inhibitor), dabigatran etexilate (direct thrombin inhibitor), or warfarin (vitamin K epoxide reductase inhibitor) can be used as oral anticoagulants for most indications. Warfarin remains first line for patients with mechanical heart valves or severe chronic kidney disease....

Repackaging dabigatran into compliance packs - October 8, 2018

Compliance packs With an ageing population there is increasing incidence of multimorbidity and polypharmacy. This leads to complex dosing regimens. Compliance aids, such as the Medico Paks® or unit dose medication sachets, are widely used to manage complex medication regimes, and help remind...
CopyrightPrivacyDisclaimerFAQs